• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Global Pharmaceutical Packaging Market is Expected to Grow at a CAGR of Over 9.5% During 2021-2030 – ResearchAndMarkets.com

Share:

February 28, 2022

The “Pharmaceutical Packaging Market Size, Share & Trends Analysis Report by Material (Plastics & Polymers, Glass), By Product (Primary, Secondary), by End-Use, by Region, and Segment Forecasts, 2021-2030” report has been added to ResearchAndMarkets.com’s offering.

The global pharmaceutical packaging market size is expected to reach USD 265.5 billion by 2030. It is expected to expand at a CAGR of 9.5% from 2021 to 2030. The increasing prevalence of chronic diseases, coupled with the growth of the pharmaceutical industry, is anticipated to augment the consumption of pharmaceutical packaging products.

Ban on counterfeit products in North America and Europe is expected to be a major driver for the market as major companies are likely to invest significantly in anti-counterfeit packaging products. Blow-Fill-Seal (BFS) technology allows customized design for high-quality containers with tamper-evident closures in multiple shapes and sizes. Therefore, the growing demand for anti-counterfeiting packaging, along with the advent of technology, is likely to support the growth of tamper-evident pharmaceutical packaging.

Companies are focusing on using sustainable materials for packaging owing to the rising concerns over the generation of packaging waste that is difficult to degrade. Bioplastic is likely to gain traction in the market as it is derived from renewable plant-based sources and is biodegradable unlike the plastics and polymers derived from fossil fuels. In December 2019, Sanner GmbH, a Germany-based packaging manufacturer, introduced BioBase effervescent tablet packaging derived from corn and sugarcane. Such novel sustainable packaging solutions are expected to boost the growth of the market.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Pharmaceutical manufacturers are likely to prefer blister packaging for tablets and capsules as these are more sustainable with minimal usage of packaging material as compared to rigid bottles. In addition, the transparency of blister packs provides a clear product display and provides tamper-resistant features. The outbreak of COVID-19 has significantly increased the demand for various pharmaceutical drugs across the world, thereby propelling the demand for pharmaceutical manufacturing and their packaging. Rapid development and production of the vaccine in the year 2020 are anticipated to increase pharmaceutical manufacturing considerably, primarily benefitting the manufacturers of packaging vials in the near future.

Market players have been trying to increase their production capabilities as well as expand their geographic reach. In addition, companies are introducing and investing in high-tech packaging solutions with the changing environment. For instance, in April 2020, Schott AG introduced smart containers, which are laser-marked with a unique identifier to create robust traceability throughout the manufacturing process. Companies are expected to invest significantly in such developments in the coming years to strengthen their market position.

Pharmaceutical Packaging Market Report Highlights

  • In terms of revenue, the glass material segment is projected to expand at the highest CAGR of 10.2% over the forecast period. Strong chemical resistance to various medicinal products and the ability to withstand heating treatment during the sterilization process is expected to expand the penetration of glass packaging
  • The contract packaging end-use segment is expected to witness the fastest growth over the forecast period. Regulatory requirements associated with pharmaceuticals and their packaging are gradually becoming stringent, and contract packaging organizations are in a better place to address those changes. This factor is boosting the demand for contract packaging services
  • The Asia Pacific is projected to be the fastest-growing regional market from 2021 to 2030. This growth is due to the rapidly expanding pharmaceutical market, particularly in China and India, and rising cases of various diseases, such as cancer and heart problems

Read more here

Source: Businesswire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • COVID-19 : 7 Predictions and 8 Bold Actions; Healthcare Will Never be the SameCOVID-19 : 7 Predictions and 8 Bold Actions; Healthcare Will Never be the Same
  • How healthcare mergers and acquisitions may actually harm patient satisfactionHow healthcare mergers and acquisitions may actually harm patient satisfaction
  • Nexelis Acquires Integrated Bioanalytical CRO AIT BioscienceNexelis Acquires Integrated Bioanalytical CRO AIT Bioscience
  • Noramco Announces the Acquisition of the Cambrex Drug Product Business UnitNoramco Announces the Acquisition of the Cambrex Drug Product Business Unit
  • Hims & Hers Taps Digital Pharmacy Alto for Same-day Medication DeliveriesHims & Hers Taps Digital Pharmacy Alto for Same-day Medication Deliveries
  • Cellix Bio Pharma Completes the Acquisition of Avaca PharmaCellix Bio Pharma Completes the Acquisition of Avaca Pharma
  • Regional Medical Center, Philips Forms 5-year, $16M Diagnostic Imaging PartnershipRegional Medical Center, Philips Forms 5-year, $16M Diagnostic Imaging Partnership
  • Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond.Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications